Affiliation:
1. Islamic Azad university
2. Tehran University of Medical Sciences
3. Shahid Beheshti University of Medical Sciences
4. Tarbiat Modares University
5. Shahid Behesthi University of Medical Sciences
Abstract
Abstract
Cisplatin is a chemotherapy drug widely used in cancer treatment. Alongside its clinical benefits, however, it may inflict intolerable toxicity and other adverse effects on healthy tissues. Due to the limitation of administering a high dose of cisplatin as well as cancer drug resistance, it is necessary to utilize new methods optimizing treatment modalities through both higher therapeutic efficacy and reduced administered doses of radiation and drugs. In this study, sensitive (A2780) and resistant (A2780CP) ovarian carcinoma cells underwent treatment with cisplatin + static magnetic field (SMF). First, the levels of genotoxicity after treatment were evaluated by Comet assay. Then, cell cycle analysis and apoptosis assay were conducted by a flow cytometer. Lastly, the expression levels of genes involved in apoptosis and cellular drug uptake were investigated by PCR. After treating different groups of cells for 24, 48, and 96 h, the co-treatment of SMF and drug as a combination managed to increase the amount of DNA damage in both sensitive and resistant cell lines. A considerable increase in mortality of cells was also observed mostly in the form of apoptosis, which was caused by inhibition of the cell cycle. The combination also increased the expression levels of apoptotic genes, namely P53 and P21; however, it did not have much effect on the expression levels of BCL2. Besides, the levels of CTR1 gene expression increased significantly in the groups receiving the aforementioned combination. Our study suggests that the combination of cisplatin + SMF might have clinical potential which needs further investigations through future studies.
Publisher
Research Square Platform LLC
Reference32 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray F;CA: a cancer journal for clinicians,2018
2. Nobiletin in Cancer Therapy; Mechanisms and Therapy Perspectives;Moazamiyanfar R;Current Pharmaceutical Design,2023
3. Combination of cisplatin treatment and photodynamic therapy attenuates cisplatin-induced cell toxicity in A2780 and A2780-CP cervical cancer cell lines;Javani Jouni F;Lasers in Medical Science,2022
4. Combined regimens of cisplatin and metformin in cancer therapy: A systematic review and meta-analysis;Jafarzadeh E;Life Sciences,2022
5. New insights into mechanisms of cisplatin resistance: from tumor cell to microenvironment;Chen S-H;International journal of molecular sciences,2019